top of page
Search
CVVT, HKUMed & HKUST joint study reports broadly neutralising antibody that protects Syrian hamsters against SARS-CoV-2 Omicron variants
Researchers at CVVT, the AIDS Institute, The University of Hong Kong (HKU), Department of Microbiology, School of Clinical Medicine, the...
CVVT
Jul 11, 2022
HKU medical experts to answer COVID-19 related queries in RTHK live TV programme
DATE: 08 Mar 2022 REF: Radio Television Hong Kong, RTHK Doctors and professors from the Department of Microbiology and the Department of...
CVVT
Mar 8, 2022
Our research reports that SARS-CoV-2 Omicron infectionrecalls mRNA-vaccine-induced immunity for broad protection
Researchers at CVVT, AIDS Institute, Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) and the...
CVVT
Jan 27, 2022
Our researchers find Omicron variant less effective in causing diseases than other variants
Our researchers have found that the Omicron variant of SARS-CoV-2 is less effective in replicating cells and causing diseases than other...
CVVT
Jan 22, 2022
Our researchers discovers a novel vaccine strategyto prevent SARS-CoV-2 nasal infection
Researchers at CVVT and the Department of Microbiology and State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of Medicine...
CVVT
Dec 29, 2021
Omicron variant isolated by our research team
Our researchers at CVVT and the Department of Microbiology at The University of Hong Kong have succeeded in the isolation of SARS-CoV-2...
CVVT
Nov 30, 2021
Six Researchers from CVVT Recognized as Highly Cited Researchers in 2021
CVVT proudly announces that six of its esteemed researchers have been honored as "Highly Cited Researchers 2021" by Clarivate,...
CVVT
Nov 16, 2021
Prof Yuen Kwok-Yung Receives 2021 Future Science Prize
Professor Yuen Kwok-Yung, our managing director, and Professor Malik Peiris (HKUMed) have been awarded the 2021 Future Science Prize in...
CVVT
Sep 13, 2021
Our researchers identifies BiIA-SG as a promising universal drug for HIV-1 prevention and functional cure
A multi-institutional research team led by scientists at the AIDS Institute and Department of Microbiology, LKS Faculty of Medicine of...
CVVT
Aug 27, 2021
Dr. Chu Hin Awarded Excellent Young Scientists Fund 2021
Dr. Chu Hin, a principal investigator of CVVT and an Assistant Professor in the Department of Microbiology at the LKS Faculty of...
CVVT
Aug 22, 2021
Our researchers develops inhaled dry powder formulationof broad-spectrum antiviral against COVID-19 and influenza
The collaborative research team formed by the Department of Pharmacology and Pharmacy and Department of Microbiology, LKS Faculty of...
CVVT
Jul 26, 2021
HKU and CEPI Extend Collaboration on Development of Nasal Spray COVID-19 Vaccine
In response to the ongoing COVID-19 pandemic, the University of Hong Kong (HKU) has extended its collaboration with the Coalition for...
CVVT
Mar 19, 2021
Our researchers found that robust SARS-CoV-2 infection in nasal turbinate underlies incomplete protection by systemic antibody or vaccine
Researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of...
CVVT
Mar 4, 2021
Prof. Kwok Yung Yuen Named Amongst the World's Most Highly Cited Researchers in 2020
Our Managing Director, Prof. Kwok Yung Yuen , has been recognized by Clarivate Analytics in the esteemed list of " 2020 Highly Cited...
CVVT
Nov 19, 2020
Breakthrough: HKU's COVID-19 Vaccine Candidate Granted Approval for Human Clinical Trial
The vaccine candidate against Covid-19 co-developed by our PIs Professor Honglin Chen and Professor Kwok-yung Yuen and HKU’s State Key...
CVVT
Sep 9, 2020
bottom of page